Teladoc Health, Inc. (TDOC)
| Previous close | 13.18 |
| Open | 13.04 |
| Bid | 0.00 x 2200 |
| Ask | 0.00 x 1300 |
| Day's range | 12.96 - 13.13 |
| 52-week range | 12.93 - 30.41 |
| Volume | |
| Avg. volume | 4,830,330 |
| Market cap | 2.208B |
| Beta (5Y monthly) | 0.94 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -1.34 |
| Earnings date | 25 Apr 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 19.70 |
ZacksAnalysts Estimate Teladoc (TDOC) to Report a Decline in Earnings: What to Look Out for
Teladoc (TDOC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
ZacksTeladoc (TDOC) Increases Despite Market Slip: Here's What You Need to Know
In the latest trading session, Teladoc (TDOC) closed at $13.14, marking a +0.08% move from the previous day.
GlobeNewswireTeladoc Health Provides Updated Start Time for First Quarter 2024 Earnings Call on April 25
PURCHASE, NY, April 15, 2024 (GLOBE NEWSWIRE) -- Teladoc Health, Inc. (NYSE: TDOC), the global leader in whole-person virtual care, announced today that the conference call to review its first quarter 2024 results, previously scheduled for 4:30 p.m. E.T. on April 25, 2024, will now start at 5:00 p.m. E.T. on that same day. Conference Call DetailsThe conference call can be accessed by dialing 1-833-470-1428 for U.S. participants and using the access code # 901506. For international participants,
